risedronic acid has been researched along with Becker Muscular Dystrophy in 2 studies
Risedronic Acid: A pyridine and diphosphonic acid derivative that acts as a CALCIUM CHANNEL BLOCKER and inhibits BONE RESORPTION.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Srinivasan, R | 1 |
| Rawlings, D | 1 |
| Wood, CL | 1 |
| Cheetham, T | 1 |
| Moreno, AC | 1 |
| Mayhew, A | 1 |
| Eagle, M | 1 |
| Guglieri, M | 1 |
| Straub, V | 1 |
| Owen, C | 1 |
| Bushby, K | 1 |
| Sarkozy, A | 1 |
| Bell, JM | 1 |
| Shields, MD | 1 |
| Watters, J | 1 |
| Hamilton, A | 1 |
| Beringer, T | 1 |
| Elliott, M | 1 |
| Quinlivan, R | 1 |
| Tirupathi, S | 1 |
| Blackwood, B | 1 |
1 review available for risedronic acid and Becker Muscular Dystrophy
| Article | Year |
|---|---|
Interventions to prevent and treat corticosteroid-induced osteoporosis and prevent osteoporotic fractures in Duchenne muscular dystrophy.
Topics: Adolescent; Adrenal Cortex Hormones; Bone Density; Bone Density Conservation Agents; Calcium; Child; | 2017 |
1 other study available for risedronic acid and Becker Muscular Dystrophy
| Article | Year |
|---|---|
Prophylactic oral bisphosphonate therapy in duchenne muscular dystrophy.
Topics: Administration, Oral; Adolescent; Bone Density; Bone Density Conservation Agents; Child; Cohort Stud | 2016 |